Over the last 7 days, the United States market has experienced a 1.5% decline, although it remains up by 16% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying stocks that are believed to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation amidst broader market growth trends.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| VSE (VSEC) | $199.33 | $386.21 | 48.4% |
| Tutor Perini (TPC) | $81.98 | $162.49 | 49.5% |
| Reddit (RDDT) | $178.44 | $354.12 | 49.6% |
| Rayonier (RYN) | $22.09 | $42.93 | 48.5% |
| Neutron Holdings (LIME) | $26.89 | $52.45 | 48.7% |
| Mobileye Global (MBLY) | $8.43 | $16.44 | 48.7% |
| Goosehead Insurance (GSHD) | $68.82 | $134.00 | 48.6% |
| FatPipe (FATN) | $5.10 | $9.99 | 48.9% |
| Dime Commercial Bancshares (DCOM) | $40.81 | $79.24 | 48.5% |
| Beacon Financial (BBT) | $29.95 | $59.31 | 49.5% |
We're going to check out a few of the best picks from our screener tool.
AbbVie (ABBV)
Overview: AbbVie Inc. is a research-based biopharmaceutical company involved in the development, manufacturing, and sale of medicines globally, with a market cap of approximately $453.91 billion.
Operations: The company generates revenue of $62.82 billion from its Innovative Medicines and Therapies segment.
Estimated Discount To Fair Value: 43.4%
AbbVie is trading significantly below its estimated future cash flow value, suggesting it may be undervalued. However, despite high debt levels and a dividend not fully covered by earnings, AbbVie's earnings are forecast to grow substantially faster than the US market. Recent European approval of RINVOQ for non-segmental vitiligo could bolster revenues. While revenue growth lags behind the market, AbbVie's strong cash flow valuation and positive product developments highlight potential investment appeal amidst financial challenges.
- Our comprehensive growth report raises the possibility that AbbVie is poised for substantial financial growth.
- Delve into the full analysis health report here for a deeper understanding of AbbVie.
Guidewire Software (GWRE)
Overview: Guidewire Software, Inc. offers a platform for property and casualty insurers globally and has a market cap of approximately $12.43 billion.
Operations: The company generates revenue primarily from its Software & Programming segment, amounting to $1.42 billion.
Estimated Discount To Fair Value: 23.7%
Guidewire Software is trading over 20% below its estimated future cash flow value, highlighting potential undervaluation. The company recently raised its earnings guidance for fiscal year 2026, projecting revenue between US$1.46 billion and US$1.47 billion and operating income up to US$134 million, driven by strong third-quarter results. Despite insider selling and a decline in quarterly net income compared to the previous year, Guidewire's earnings are expected to grow significantly faster than the market over the next three years.
- In light of our recent growth report, it seems possible that Guidewire Software's financial performance will exceed current levels.
- Navigate through the intricacies of Guidewire Software with our comprehensive financial health report here.
Unity Software (U)
Overview: Unity Software Inc. provides a platform for creating and expanding games and interactive experiences across various devices globally, with a market cap of approximately $13.29 billion.
Operations: The company's revenue primarily comes from its Software Solutions segment, which generated $1.92 billion.
Estimated Discount To Fair Value: 46.7%
Unity Software is trading 46.7% below its estimated future cash flow value of US$59.69, suggesting potential undervaluation. Despite a significant net loss of US$347.61 million in Q1 2026, Unity's earnings are forecast to grow rapidly at 76.36% annually, with profitability expected within three years. However, recent insider selling and removal from several growth benchmarks may raise concerns among investors about the company's short-term prospects and market positioning.
- Our earnings growth report unveils the potential for significant increases in Unity Software's future results.
- Click here to discover the nuances of Unity Software with our detailed financial health report.
Key Takeaways
- Take a closer look at our Undervalued US Stocks Based On Cash Flows list of 154 companies by clicking here.
- Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Interested In Other Possibilities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com